The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Open accessAbstract
oronavirus disease 2019 (COVID-19) is a pandemic viral disease with its origin in Wuhan, China, in December 2019. 1 As of March 20, 2020, 244 602 patients have tested positive worldwide; and 10 031 (4.1%) of these patients were reported to be deceased because of COVID-19.2 According to the Chinese Center for Disease Control and Prevention, as of February 11, 2020 with 44 672 confirmed patients, several comorbidities, including cardiovascular diseases and diabetes mellitus, seem to be involved in COVID-19 patients with a severe course.3 In this largest analysis, 10.5% of fatal cases occurred in patients with cardiovascular disease and 6% in patients with arterial hypertension.3 It is unclear whether these comorbidities contribute to the higher risk.A recently published single-center study on 99 hospitalized patients in China showed that 40% of the cohort had cardiovascular or cerebrovascular disease and 12% had diabetes mellitus.10 In another Chinese
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed Central · Cited by 1,278
Preventing a covid-19 pandemic
Watkins, J. (2020) · BMJ · doi:10.1136/bmj.m810 · Cited by 474
Guo, J., Huang, Z., Lin, L., & Lv, J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016219 · Cited by 464
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
Bozkurt, B., Kovacs, R., & Harrington, B. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.013 · Cited by 355
Angiotensin-Converting Enzyme Inhibitors in Hypertension
Messerli, F. H., Bangalore, S., Bavishi, C., & Rimoldi, S. F. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.058 · Cited by 349
Self-citationHuman intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
Vuille-dit-Bille, R. N., Camargo, S. M., Emmenegger, L., Sasse, T., Kummer, E., Jando, J., Hamie, Q. M., Meier, C. F., Hunziker, S., Forras-Kaufmann, Z., et al. (2015) · Amino Acids · doi:10.1007/s00726-014-1889-6 · Cited by 312
Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
Gu, H., Xie, Z., Li, T., Zhang, S., Lai, C., Zhu, P., Wang, K., Han, L., Duan, Y., Zhao, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep19840 · Cited by 246
Estimation of risk factors for COVID-19 mortality - preliminary results
Caramelo, F., Ferreira, N., & Oliveiros, B. (2020) · medRxiv · doi:10.1101/2020.02.24.20027268 · Cited by 236
Igase, M., Strawn, W. B., Gallagher, P. E., Geary, R. L., & Ferrario, C. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2005 · Cited by 203
Walters, T. E., Kalman, J. M., Patel, S. K., Mearns, M., Velkoska, E., & Burrell, L. M. (2016) · Europace · doi:10.1093/europace/euw246 · Cited by 162
The ANG-(1–7)/ACE2/mas axis in the regulation of nephron function
Ferrario, C. M., & Varagić, J. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2010 · Cited by 151
Circulating ACE2 activity correlates with cardiovascular disease development
Katalin, Ú., Fagyas, M., Kertész, A., Borbély, A., Jenei, C., Bene, O., Csanádi, Z., Paulus, W. J., Edes, I. F., Papp, Z., et al. (2016) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320316668435 · Cited by 137
Derington, C. G., King, J. B., Herrick, J. S., Shimbo, D., Kronish, I. M., Saseen, J. J., Muntner, P., Moran, A. E., & Bress, A. P. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14360 · Cited by 134
Sex differences in the aging pattern of renin–angiotensin system serum peptidases
Fernández‐Atutxa, A., Izagirre, A., Fraile-Bermúdez, A. B., Kortajarena, M., Larrinaga, G., Martínez‐Lage, P., Echevarría, E., & Gil, J. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0128-8 · Cited by 115
Katalin, Ú., Fagyas, M., Siket, I. M., Kertész, A., Csanádi, Z., Sándorfi, G., Clemens, M., Fedor, R., Papp, Z., Edes, I. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087845 · Cited by 92
ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1–7)
Chappel, M., & Ferrario, C. M. (2006) · Kidney International · doi:10.1038/sj.ki.5000321 · Cited by 81
Cited by
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,409
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 592
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Zabetakis, I., Lordan, R., Norton, C., & Tsoupras, A. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 532
de Abajo, F. J., Rodríguez-Martín, S., Lerma, V., Mejía-Abril, G., Aguilar, M., García-Luque, A., Laredo, L., Laosa, O., Centeno-Soto, G. A., Ángeles Gálvez, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31030-8 · Cited by 408
Metadata
- Authors
- Sommerstein, R., Kochen, M. M., Messerli, F. H., & Gräni, C.
- Venue
- Journal of the American Heart Association
- Published
- 2020-04-09
- Volume
- 9
- Issue
- 7
- Pages
- e016509-e016509
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W3013529907
- Cited by
- 254
- References
- 26
- FWCI
- 33.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.